Business
GPX: Sales declined but financing and R&D investments support future growth in quality control markets
GPX: Sales declined but financing and R&D investments support future growth in quality control markets
About this update from Gasporox Ab
Q1 2025 saw lower sales and a negative operating result, but strong cash flow from new convertible loan financing. Strategic investments in technology and product development position Gasporox for future growth in expanding quality control markets.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.